Your browser doesn't support javascript.
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany's Largest Public Health Department (Cologne).
Hsu, Lea; Grüne, Barbara; Buess, Michael; Joisten, Christine; Klobucnik, Jan; Nießen, Johannes; Patten, David; Wolff, Anna; Wiesmüller, Gerhard A; Kossow, Annelene; Hurraß, Julia.
  • Hsu L; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Grüne B; Institute for Occupational Medicine and Social Medicine, University Hospital, Medical Faculty, RWTH Aachen University, 52056 Aachen, Germany.
  • Buess M; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Joisten C; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Klobucnik J; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Nießen J; Department for Physical Activity in Public Health, Institute of Movement and Neurosciences, Am Sportpark Müngersdorf 6, German Sport University Cologne, 50933 Cologne, Germany.
  • Patten D; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Wolff A; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Wiesmüller GA; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Kossow A; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
  • Hurraß J; Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
Vaccines (Basel) ; 9(11)2021 Nov 02.
Article in English | MEDLINE | ID: covidwho-1502537
ABSTRACT
BACKGROUND AND

METHODS:

Vaccination is currently considered the most successful strategy for combating the SARS-CoV-2 virus. According to short-term clinical trials, protection against infection is estimated to reach up to 95% after complete vaccination (≥14 days after receipt of all recommended COVID-19 vaccine doses). Nevertheless, infections despite vaccination, so-called breakthrough infections, are documented. Even though they are more likely to have a milder or even asymptomatic course, the assessment of further transmission is highly relevant for successful containment. Therefore, we calculated the real-world transmission risk from fully vaccinated patients (vaccination group, VG) to their close contacts (CP) compared with the risk from unvaccinated reference persons matched according to age, sex, and virus type (control group = CG) utilizing data from Cologne's health department.

RESULTS:

A total of 357 breakthrough infections occurred among Cologne residents between 27 December 2020 (the date of the first vaccination in Cologne) and 6 August 2021. Of the 979 CPs in VG, 99 (10.1%) became infected. In CG, 303 of 802 CPs (37.8%) became infected. Factors promoting transmission included non-vaccinated status (ß = 0.237; p < 0.001), male sex (ß = 0.079; p = 0.049), the presence of symptoms (ß = -0.125; p = 0.005), and lower cycle threshold value (ß = -0.125; p = 0.032). This model explained 14.0% of the variance (corr. R2).

CONCLUSION:

The number of transmissions from unvaccinated controls was three times higher than from fully vaccinated patients. These real-world data underscore the importance of vaccination in enabling the relaxation of stringent and restrictive general pandemic control measures.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9111267

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9111267